§1105.6. Reports; liability for
A. No action for damages arising from the disclosure of confidential or privileged
information may be maintained against any person, or the employer or employee of any
person, who participates in good faith in the reporting of cancer registry data or data for
cancer morbidity or mortality studies in accordance with this Part.
B. No license of a health care provider may be denied, suspended, or revoked for
good faith disclosure of confidential or privileged information or the reporting of cancer
registry data or data for cancer morbidity studies in accordance with this Part.
C. Nothing in this Part shall be construed to apply to the unauthorized disclosure of
confidential or privileged information when such disclosure is due to gross negligence or
willful misconduct.
D. All information reported pursuant to this Part shall be confidential and privileged.
The president shall take strict measures to ensure that all identifying information is kept
confidential.
E. All information regarding case-specific data, as distinguished from group, tabular,
or aggregate data concerning patients or health care providers contained in records of
interviews, written reports, and statements procured by the president or by any other person,
agency, or organization acting in connection with cancer morbidity and mortality studies
shall be confidential and privileged and shall be used solely for the purposes of the study.
Nothing in this Section shall prevent the president from publishing compilations relating to
morbidity and mortality studies which do not identify case-specific data or sources of
information.
Added by Acts 1978, No. 653, §1; Acts 1995, No. 1197, §1, eff. June 29, 1995; Acts
2001, No. 197, §1; Redesignated from R.S. 40:1299.85 by HCR 84 of 2015 R.S; Acts 2018,
No. 206, §4.